Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02875223
Title A Safety and Efficacy Study of CC-90011 in Subjects With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene

prostate neuroendocrine neoplasm

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

Advanced Solid Tumor

neuroendocrine tumor

diffuse large B-cell lymphoma

follicular lymphoma

lung small cell carcinoma

pulmonary neuroendocrine tumor



Age Groups: senior | adult
Covered Countries ITA | FRA | ESP

No variant requirements are available.